SCHEMBL27299269

SCHEMBL27299269

CCCCCC(CCOC(=O)CCC1CCCCC1)CCC(CCC(CCCCC)CCSC1CCCC[C@H]1OC(=O)CCC1CCCCC1)N(C)CCCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27303854 1.00 — —
SCHEMBL30977727 1.00 — —
SCHEMBL31035860 0.92 NAAA (0.34) —
SCHEMBL27303835 0.92 NAAA (0.34) —
SCHEMBL27299268 0.92 NAAA (0.34) —
SCHEMBL27303517 0.89 SLC2A1 (0.30) —
SCHEMBL30977721 0.85 — —
SCHEMBL31035922 0.85 NAAA (0.33) —
SCHEMBL27302323 0.85 NAAA (0.33) —
SCHEMBL27299265 0.82 TLR2 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024130421-A1 SULFUR-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF NUCLEIC ACIDS AND OTHER THERAPEUTIC AGENTS NANOVATION THERAPEUTICS INC. (CA) 2024-06-27 — — WO disclosed
Send feedback